Download - US & EU GMP Guidelines on Analytical Instrument Qualification and Related Warning Letters
April 21, 2023
Confidentiality Label
1
US & EU GMP Guidelines on Analytical Instrument Qualification and Related Warning Letters
Copyright Slide 2
Overview
• FDA/EU/USP Requirements and enforcement practices
• Examples of FDA warning letters• The 4Q model for equipment qualification• Essential steps and example templates for Instrument
Qualification: DQ, IQ, OQ, PQ• Validation of existing systems• Requalification: what, when
Reference material: www.labcompliance.com/agilentAvailable until March 10, 2014
Copyright Slide 3
Regulations and Quality Standards
• Good Laboratory Practices
• GMP Manufacturing Practices
• Good Clinical Practices
• 21 CFR Part 11: E-Records&signatures
• IS0 17025
• Equipment should be suitable for its intended use• Equipment should be calibrated and maintained
Copyright
Slide 4
US FDA; 21 CFR Part 211 - 211.68• Automatic, mechanical, or electronic equipment or other
types of equipment, including computers, or related systems that will perform a function satisfactorily, may be used in the manufacture, processing, packing, and holding of a drug product
• If such equipment is so used, it shall be routinely calibrated, inspected, or checked according to a written program designed to assure proper performance. Written records of those calibration checks and inspections shall be maintained.
Copyright
Slide 5
Other Regulations and GuidelinesEurope•EU GMP Annex 15 (draft February 2014)
– Validation and qualification activities should consider all stages from initial development of the user requirements specification through to the end of use of the equipment
– Steps include: User requirement specifications, design qualification, installation qualification, operational qualification and performance qualification (4Q model)
United States Pharmacopeia
•.USP general chapter <1058>: “Analytical Instrument Qualification”
– Global standard for laboratory equipment qualification
– Follows the 4Q model (see Annex 15 above)
Copyright Slide 6
FDA Warning Letters• Failure of your quality control unit/laboratory to
ensure that analytical instrumentation and test equipment used to assure the quality of your APIs has been appropriately qualified and calibrated for their intended use.
• All laboratory instrumentation and equipment that you use to test material manufactured for the U.S. market should have an Operational Qualification (OQ) and should be calibrated to include applicable operating ranges (W-288)
Ref: www.fdawarningletter.com
Perform Operational Qualification Equipment
Copyright Slide 7
FDA Warning Letters• Lacks documentation of installation and operation qualification of equipment (160)
• The Validation Master Plan does not contain an operational qualification for xxx (164)
• There is no requirement for a Performance Qualification protocol (164)
Ref: www.fdawarningletter.com
Perform IQ/OQ/PQ for Equipment
Copyright Slide 8
FDA Warning Letter/483/EIR• The calibration program for your stability chambers is
deficient ill that it does not include specific directions and schedules.
• You do not perform re-qualification of the stability chambers.
1. Develop a program for equipment calibration and calibration. Include a schedule
2. Conduct regular requalification of equipment
–
Copyright Slide 9
FDA Warning Letters
• Failure to have a complete calibration program for the HPLCs in that the gradient accuracy and detector linearity is not being verified (W-110)
Ref: www.fdawarningletter.com
Perform Operational Qualification for all equipment functions
Copyright Slide 10
FDA Warning Letters
• No chromatographic system suitability testing (W-016)
Ref: www.fdawarningletter.com
1. Develop written procedures for type and frequency of system suitability testing
2. Ensure that the procedure is followed
Copyright Slide 11
Analytical Instrument Qualification and and other Quality Checks
• Quality control checks– Verifies accuracy of sample analysis
• System suitability tests– Verifies that the system performs according to
analysts expectations• Analytical methods validation
– Proof that analytical procedure does what it purports to do
• Analytical instrument qualification– Forms the base for generating quality data– Proof suitability of the instrument for intended
use
Copyright Slide 12
Design Qualification
Installation Qualification
Operational Qualification
Performance Qualification
Qualification/Validation Phases 4Q Model
User requirement specifications Functional specifications Operational specifications Vendor qualification
Check arrival as purchased Check proper installation of
hardware and software Test of operational functions Performance testing Test of security functions
Test for specified application Preventive maintenance On-going performance tests
Required by FDA, Europe and USP
Copyright Slide 13
Design Qualification (DQ) Activities and Documentation
• Vendors– Design, develop and manufacture instruments in quality control environment, e.g., ISO 9001:2008– Develop functional and operational product specifications
• Users– Develop user requirement specifications– Verify that the vendor’s instrument meets user’s requirements: product specifications, delivery
and support– Verify that the vendor operates in a quality system environment
Copyright Slide 14
Design Qualification - Template
Function/Performance
User Requirement
Supplier Specification
Commentyes/no
Function 1
Function 2
Physical Requirements
Construction Requirement
Vendor Requirement
Documenting Equipment Supplier Selection Items Required Results Passed
Recognition in the market place □ yes □ no
Experience with the vendorReliability, response to problems
□ yes □ no
Quality assurance
ISO 9001:2008 Certification □ yes □ no
Documented Software Development. □ yes □ no
Support
Provide specifications list □ yes □ no
Installation service □ yes □ no
IQ/OQ services with Certificates □ yes □ no
Phone and onsite support □ yes □ no
Equipment functionality
Products has required functions □ yes □ no
Slide 15
Copyright Slide 16
Installation Qualification (IQ)Vendor•Provides the user with environmental specifications and a site prep document•Provides •Offers services for IQ with inspection ready documentationUser •Verify that facilities, utilities, and environment meet vendor requirements•Assemble and install equipment•Perform initial diagnostics and testing•For complex equipment: run reference sample •Document installation, including drawings
Equipment lacks documentation of installation and operation qualification (160)
Copyright Slide 17
Equipment Documentation for IQ
Identification
Manufacturer Best HPLC
Model D4424A
Firmware revision 1.00
Serial Number E4431A
Internal ID (Asset number) D33243
Current location Glab4
Size (w x b x h) (cm) 30x22x7
Condition when installed New
Supplier contact phone for services
1+541-64532
Example: HPLC detector
Copyright Slide 18
Operational Qualification (OQ)
Vendor• Provides services for OQ with traceable tools• Delivers inspection ready OQ documentation• Makes recommendations for frequency of requalificationUser• Test functions to verify that the instrument operates in the
user’s environment as intended by the manufacturer and required by the user.
• Test secure data handling, storage, back-up and archiving• Tests can be holistic or modular. • Tests can be done by users or qualified designees.
Conductivity meters not calibrated to a NIST traceable device (156)
Copyright Slide 19
OQ Test - Example
Date Weight 1Weight 2 Test engineerName Signature
Weight 3 o.k.
yes9999.8 999.9 100.0 Hughes2/3/06
Instrument BestBalance
Serial number 55236A
Maximal weight 11 g
Control weight 1 10,000 mg Limit +-10 mg
Control weight 2 1,000 mg Limit: +-1 mg
Control weight 3 100 mg Limit: +- 0.1 mg
Copyright Slide 20
Performance Qualification (PQ) Vendor• Provides recommendation for PQ tests, e.g., for system suitability
testing• Provides software for PQ testing, e.g., for system suitability and quality
control chartsUser • Preventive maintenance to ensure trouble free operation for the
intended application• Performance checks, based on the instrument’s typical on-site
applications– Test frequency depends on the ruggedness of the instruments and
the criticality of the tests– System suitability and QC tests can imply suitable performance
There is no requirement for a Performance Qualification protocol (164)
Copyright Slide 21
Documentation of PQ Testing
Test Test Case
Expected result Actual Result
Pass/Fail
BaselineNoise
T10 <1x10-4 AU Pass
Resolution between compound A and B
T11 >2.0
Tailing factor T12 <1.3
Precision of amount compound A, 6 replicate injections
T13 <1%
Precision of amount compound B, 6 replicate injections
T14 <1%
Example: HPLC System
Copyright Slide 22
Summary Report TemplateScope of the report
Product Description
Qualifiaction Strategy
Responsibilities
Supplier Assessment
Risk assessment
Testing Strategies
DQ
IQ
OQ
PQ
Traceability matrix
Procedures
Deviations
Approval
Documentation control
Copyright Slide 23
Define System Use
Installation Qualification
Operational Qualification
Performance Qualification
Validation Phases – 4Q Model APPROACH FOR EXISTING EQUIPMENT
Document equipment use Document applications Document used functions
Enter all modules and systems in a database
Hardware, Firmware, Software
Document past tests Test of functional specifications Test of performance functions
System test (system suitability testing)
Preventive maintenance
+ Change Control
Copyright Slide 24
OQ - Requalification
• Required – when the instrument undergoes major
repairs or modification– After transport to an other location, if the
move ‘disturbs’ instrument operation• May not be required to be repeated at
regular intervals
No recalibration after equipment move (154)The calibration program for your stability chambers is deficient in that it does not include specific directions and schedules.(231)
Ludwig HuberLabcompliance Sponsored by Slide 25
Thank YouI would like to thank • All attendees for your attention• Agilent Technologies for invitation and organization
For links to Analytical Instrument Qualification references, please checkwww.labcompliance.com/agilent(Available until March 10, 2014)
Dr. Ludwig [email protected]